{"name":"Radiopharm Theranostics, Ltd","slug":"radiopharm-theranostics-ltd","ticker":"","exchange":"","domain":"radiopharmtheranostics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"LNTH-2403","genericName":"LNTH-2403","slug":"lnth-2403","indication":"Other","status":"phase_1"},{"name":"177Lu-RAD202","genericName":"177Lu-RAD202","slug":"177lu-rad202","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"177Lu-BetaBart","genericName":"177Lu-BetaBart","slug":"177lu-betabart","indication":"Neuroendocrine tumors","status":"phase_1"},{"name":"177Lu-RAD204","genericName":"177Lu-RAD204","slug":"177lu-rad204","indication":"Neuroendocrine tumors","status":"phase_1"}]}],"pipeline":[{"name":"LNTH-2403","genericName":"LNTH-2403","slug":"lnth-2403","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"177Lu-BetaBart","genericName":"177Lu-BetaBart","slug":"177lu-betabart","phase":"phase_1","mechanism":"Targeting somatostatin receptors","indications":["Neuroendocrine tumors"],"catalyst":""},{"name":"177Lu-RAD202","genericName":"177Lu-RAD202","slug":"177lu-rad202","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"177Lu-RAD204","genericName":"177Lu-RAD204","slug":"177lu-rad204","phase":"phase_1","mechanism":"Alpha-particle emitting radioligand targeting somatostatin receptors","indications":["Neuroendocrine tumors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQjBLX3ZuZExZVXhLUzFUTTJ3cGpzSS1aMExLUjFrY2JnWWp4UGZTSkhpeHg1SS11WjFQQWhxQlY1N3Juei13YlNycEhmdkFWVmxSZ0FUai0wNW9oN3RycFlMMV9uSDBaZGtja1JsUTFfMkYwdjZFOE55dEhseFV4UmNJNW52WDBlY3VpcTJINVFYSlduWE45TWZZdnhnQkhGbE91cXB6RUZJMFd2VERNaW04UFVXRkdE?oc=5","date":"2026-04-07","type":"trial","source":"Stock Titan","summary":"Brain metastases scan moves toward Phase 3 with Siemens supply deal - Stock Titan","headline":"Brain metastases scan moves toward Phase 3 with Siemens supply deal","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOOUN4djkzOHRvWkdGV0h1UnpZMzVKb2NaU09WU0xuSDVEaDJNck5aX1FCLUtQZXEzR3BUQUljN2ZnVWVGeExTcF9Pa2R2UHhzek5KMDMyUGJmaDF3WUJ5MkU5X2NFOVN0dXhVcFdmZXlpS29EdDB0SDF3eEZUZ3hXQVZ6WXQ2b3pRWnBqdnktLW5ETXU5eE5RSHVyRFNESVBQVVVTQlNUSUNLdUVPSldhUC1lZ1U1c1lub0ZOemhpdWo0b2owRkNxQkExd29yZFBHY2g4MDJrcUxoYzBjclc4NDdYMmdjV1VlQ3Z2VDE4cU0xMzFobXMwYm9fWlNGLWxhS0l0X0kwaGYwbUhFRXRQY01sbG8?oc=5","date":"2026-02-24","type":"trial","source":"prnewswire.com","summary":"AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01) - prnewswire.com","headline":"AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-Be","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQTm1XUHZzeG1Mb2hJMzZoU202SVpHZ0dRQWxvWnA0bkxSVnRINjZFV0pEMDFxQWtoVU1IQkVNdDgyV29EZjMxRnZuM1VTWjZFSWNRYTBxTnU3RWVyRFBEYnQyRHBGQlJwdXZmUnhtd0dJcHlpYkx4YnpaMGVya2dtMVdzU2M3ZHpEVC1wZjNWaGFJY0hxM1kyd1NQQ1Myc0s0enNJbkdpRG8zamV0dnBFRUZVOTRxb0djQVVsUlc1XzZXd04zZ2IyaElULUliZmhiYTJDcHdRb3Zsb2pWRWk0Y1BObU9Fd0ZqOEFpZ0xBR21sd9IB9wFBVV95cUxOenFEcUlYWlJ3WE4yM0pMVmM2YXpmRDNaMXBBWXhaZGx3Z1U5emJmcHpvdGZEWmRpRUt3ZmF1OWtITXJ0LVBicnNiRk1mOGVwbFFXb0JqZklZN2VRVUZGdlRoZmhFWjlnRU9nU3ZYd01pTG5mTDZ6c3VINnVKVnAtU1JhYmZHY2JwS0J6LU1NX21jaGRtM2tYcWpVd0pmb1FxRnVwWmNibm5mUDN3YTgzd2F4V2ZndXlubU1OZnNodWI1dklkZER3Q0dGbEp5d3FCZ1VFbUtFSWt6N1RkSUNBWmQ2RnBKREVZR2NkdFdBZjRITkpJR3dN?oc=5","date":"2026-01-22","type":"pipeline","source":"simplywall.st","summary":"Radiopharm Theranostics Slides As Insider Purchases Lose Another AU$25k - simplywall.st","headline":"Radiopharm Theranostics Slides As Insider Purchases Lose Another AU$25k","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeG8wUC1uYXNRUTlZREVrRjdMRFdVWTloZm1kbWJxRnlUVjRsdU92VUplNUt2UHVYUDZha0FRVUZ4bW13V2VTVXE2SjJMSWZuNFl5YmNTUERsNUNSZDZZVURaR2pDZ0Rmald5amQ5YlNOdURvZzFITlNQTndtNUZxZGUta0NnTTEtVzdTVXN6QmdUVmttQ2lGdFlvRjJYN1RqYnJ6d1dicjA?oc=5","date":"2025-12-16","type":"trial","source":"BioWorld News","summary":"Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints - BioWorld News","headline":"Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQdllPZ2RtV0N2a0ZVdUM3RFBBTDlyckJzUndIMmpqZVYwUFNQR0haN0Z2cXZXZjk3bGRYaG54cFJ5WUlIcXdoX0Iyd1ZrX213OGtqNWRkcWdQSTQ4OHBLSS0xdXRDU2NTOHNBVzhoX0tpaW9pYjBpcWpWTF9jdkZDNmVRdjVXbnZOZ2tDR3hFQnI?oc=5","date":"2025-12-15","type":"deal","source":"timothysykes.com","summary":"Radiopharm Theranostics Surge: Buy or Sell? - timothysykes.com","headline":"Radiopharm Theranostics Surge: Buy or Sell?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNXRHbDR5M2RxZFNFSWNTR0VHNkN6SlFtN1k3VUNxTEM2V1licjMwRVBCbzlrTm0zRzJfcFVoSEZ6RWpnZFItZ3hVZGhxcGhwbVljMWdtOVlWY0xLWWlwTkJvUzZURG1VYTlsVXZhd2FGazZaRkE0NTZ5ZUZsb3kzT2NyRnp1N2J6TWFpLXZudmd5OTNpRjR0TG5nZlhDUUxPQVBfTlZJVGhNbDdId0tBcWlPRERxVzZKdDVVRWNxa3dUdEhXSHI4VUxWQzcwQWNscm9YYlJUQ2Z1NURkbVc1NXFadw?oc=5","date":"2025-10-23","type":"pipeline","source":"GlobeNewswire","summary":"Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica - GlobeNewswire","headline":"Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQejNFUE53M0d3bVR1SG9aLS1IZEY4OXl1Q1BNY182M3JzZ0dCN016Y2ZuUFliYUJzNU9FR3FocXFjaE1xckRPRjBqWGNuSm05SXJ6NEd0TDVJbUdvZV9VMWE5bjZDU04xVFZIN0RmM0k4VkhuYVoyYTJCMkszTFZQR2JIYjctVHdIQmxBVUpMSzRFX0ZZMzJFeU1Bd0RPdHV5RFJ0alVZUUtqNnNv?oc=5","date":"2025-09-30","type":"deal","source":"smallcaps.com.au","summary":"Starpharma and Radiopharm Theranostics Partner to Develop Novel Radiotherapy Asset - smallcaps.com.au","headline":"Starpharma and Radiopharm Theranostics Partner to Develop Novel Radiotherapy Asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbW1XY3pFamxBYW9sc1dxSWhsZkFmOHlMNUhVNHc5SVdwa18zSDdwZWJBaDBZUFZBX0NNQ3BfNlluaU9JN1RTbldVX3phLXZVZl9zTF9DN1BHMWEzWDdGODFGR2dVUWNIT2Q1MnRCYXRVdXFLMlpRT2FJWjUyaWp3aEtBTzNrWkR4a2dlTlNWUUNkOVplX01ZMzcwblJYYUlSOWZOTXZPM19NR2s4Um9YOVpPeHM2NC1qOGtz?oc=5","date":"2025-09-30","type":"pipeline","source":"The Motley Fool Australia","summary":"This biotechnology stock just ticked over 100% gains for the month on more good news - The Motley Fool Australia","headline":"This biotechnology stock just ticked over 100% gains for the month on more good news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNR0twSHktVk9leUVGV0wyVHBycDh6VjFabXRJQnhQSkNzamJOWjBoSFVmSHltYUpTcXV0dXJ6TEhtVFNhdlNIMGwwYlBmbFFtT1FBX1lkV1VuTWVqQ3ZXMjZKaXJ3V1Y0TXdwMk5kWU0ya0Z3RlNPTUN2MVN4akVSRVgyTFBPdERVN0tBc3B3Wk52MEx1aGZvTU9tVVNOanBwZUtjNDFmVXJ4OG1uT1R4bnd3djFERXB2WVdZ?oc=5","date":"2025-05-26","type":"pipeline","source":"Forbes Australia","summary":"Australian startups take on big pharma with precision cancer breakthroughs - Forbes Australia","headline":"Australian startups take on big pharma with precision cancer breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQR2pmLWY2dnhVMGVCLWtHTDJYOFZtRlJ0aFBvbVlFbjZIVUhEU0ppRVhEbWxoU2lpM2VSTDZUZUZ5SE5vWUF6WmpWejhrQ0phWEVyTm53aUl1b2RDaGJkS1M3NVBDeUFVTjVtcGR1YS1kRnhIdjZ6ZFFRQzNpODVNWjk5Q1NZV3ZXY2hWUmR3dlZmTlFIOTZLaHlQMVJycGtLX1FJckp3cTY4dw?oc=5","date":"2025-05-09","type":"pipeline","source":"The Pharma Letter","summary":"M&A activity – Radiopharmaceutical therapies are a hot target for investment - The Pharma Letter","headline":"M&A activity – Radiopharmaceutical therapies are a hot target for investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQR2xqNkhRSWpuVHdqSVVVclY4VlpWd29LY0ZBQmZLYzhvbmtDcm9VeVI2Q2VoVlFoY3l5YU53U3lYWWE5dkVUSXktelVPZ3VRNXk5Mmx4WXZ3S0pDTkF3ckdoTXI5NXZkd3l6OTFxSmpRZWluODdIZUY0SGo4d25tb2xOR1VkWWx2Y0RkcnBGSGx1dw?oc=5","date":"2025-03-17","type":"pipeline","source":"Pharma Voice","summary":"Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do - Pharma Voice","headline":"Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8xS2duWXc0aWl4SDNZZlZPbDd3YnVZQUwwS1lyOTNsZDQ5ZUVfT0x3RmZjUDViYjE5aWNRamg5Y3Z0dlJ0Umo5aXE4VFYwR3hPQ1ZzU184RmxxWDJVN0xF?oc=5","date":"2025-01-03","type":"pipeline","source":"Nature","summary":"Radiopharmaceuticals and their applications in medicine | Signal Transduction and Targeted Therapy - Nature","headline":"Radiopharmaceuticals and their applications in medicine | Signal Transduction and Targeted Therapy","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}